Table 4.
Antibiotic susceptibility of isolates.
| Antibiotics | Disc Potency (µg) | B-2 | B-5 | B-11 | B-14 | B-19 | B-21 | B-28 | B-33 |
|---|---|---|---|---|---|---|---|---|---|
| Ampicillin | 10 | S | S | S | S | S | S | S | S |
| Cephalothin | 15 | S | S | S | S | S | S | S | S |
| Chloramphenicol | 50 | S | S | S | S | S | S | S | S |
| Cloxacillin | 20 | S | S | S | S | S | S | S | S |
| Erythromycin | 10 | S | S | S | S | S | S | S | S |
| Fusidic acid | 10 | R | R | R | R | R | R | R | R |
| Gentamicin | 10 | R | R | R | R | R | R | R | R |
| Kanamycin | 30 | R | R | R | R | R | R | R | R |
| Nalidixic acid | 20 | R | R | R | R | R | R | R | R |
| Neomycin | 20 | R | R | R | S | R | R | R | R |
| Novobiocin | 30 | S | S | S | S | S | S | S | S |
| Penicillin | 10 | S | S | S | S | S | S | S | S |
| Polymyxin B | 20 | R | R | R | R | R | R | R | R |
| Rifampicin | 20 | R | R | R | R | R | S | R | R |
| Spectinomycin | 10 | S | S | S | S | S | S | S | S |
| Streptomycin | 25 | R | R | R | R | R | S | R | R |
| Tetracycline | 30 | S | S | S | S | S | S | S | S |
| Vancomycin | 30 | S | S | S | S | S | S | S | S |
Where, inhibition zone diameter <8 mm, resistant (R); inhibition zone diameter between 8–10 mm, moderate (M) and inhibition zone diameter >10 mm, susceptibility (S).